PAVmed Inc. (NASDAQ:PAVM) Q2 2022 Earnings Conference Call August 16, 2022 4:30 PM ET

Company Participants

Adrian Miller - VP, IR

Lishan Aklog - Chairman and CEO

Dennis McGrath - President and CFO

Conference Call Participants

Ross Osborn - Cantor Fitzgerald

Frank Takkinen - Lake Street Capital Markets

Edward Woo - Ascending Capital

Anthony Vendetti - Maxim Group

Operator

Greeting. Welcome to the PAVmed Inc. Second Quarter 2022 Business Update Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded.

I'll now turn the conference over to Adrian Miller, Vice President of Investor Relations. Sir, you may begin.

Adrian Miller

Thank you, operator. Good afternoon, everyone. This is Adrian Miller, Vice President of Investor Relations at PAVmed. Thank you for participating in today's business update call.

Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer of PAVmed, along with Dennis McGrath, President and Chief Financial Officer of PAVmed.

The press release announcing our business updates and financial results will be available shortly on PAVmed's website. Please take a moment to read the disclaimer about the forward-looking statements in the press release. The business update press release and this conference call, both include forward-looking statements and these forward-looking statements are subject to known and unknown risks and uncertainties, that may cause actual results to differ materially from the statements made.

Factors that could cause actual results to differ are described in the disclaimer and in our filings with the Securities and Exchange Commission. For a list of those description - and other risks and uncertainties that may affect the future operations, see Part 1, Item 1A entitled Risk Factors in PAVmed's most recent annual report on Form 10-K filed with the Securities and Exchange Commission and any subsequent updates filed in quarterly reports on Form 10-Q and subsequent Form 8-K filing.

Except as required by law, PAVmed disclaim any intentions or obligations to publicly update or revise any forward-looking statements to reflect changes in expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.

With that, I'd like to turn the call over to Lishan Aklog. Dr. Aklog?

Lishan Aklog

Thank you, Adrian and good afternoon, everyone. Thank you for joining our quarterly update call.